Vivo Ventures Fund Vii, L.p. - Net Worth and Insider Trading
Vivo Ventures Fund Vii, L.p. Net Worth
The estimated net worth of Vivo Ventures Fund Vii, L.p. is at least $8.6 Billion dollars as of 2024-05-06. Vivo Ventures Fund Vii, L.p. is the 10% Owner of American Express Co and owns about 36,984,282 shares of American Express Co (AXP) stock worth over $8.5 Billion. Vivo Ventures Fund Vii, L.p. is the 10% Owner of Codexis Inc and owns about 5,294,825 shares of Codexis Inc (CDXS) stock worth over $21 Million. Vivo Ventures Fund Vii, L.p. is also the 10% Owner of Aclaris Therapeutics Inc and owns about 2,858,569 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $4 Million. Details can be seen in Vivo Ventures Fund Vii, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vivo Ventures Fund Vii, L.p. has not made any transactions after 2018-08-30 and currently still holds the listed stock(s).
Transaction Summary of Vivo Ventures Fund Vii, L.p.
Vivo Ventures Fund Vii, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivo Ventures Fund Vii, L.p. owns 4 companies in total, including Sierra Oncology Inc (SRRA) , Codexis Inc (CDXS) , and Aclaris Therapeutics Inc (ACRS) among others .
Click here to see the complete history of Vivo Ventures Fund Vii, L.p.’s form 4 insider trades.
Insider Ownership Summary of Vivo Ventures Fund Vii, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SRRA | Sierra Oncology Inc | 2015-07-15 | 10 percent owner |
| CDXS | Codexis Inc | 2016-09-08 | 10 percent owner |
| ACRS | Aclaris Therapeutics Inc | 2017-03-02 | 10 percent owner |
 | | 2012-12-18 | 10 percent owner |
Vivo Ventures Fund Vii, L.p. Latest Holdings Summary
Vivo Ventures Fund Vii, L.p. currently owns a total of 3 stocks. Among these stocks, Vivo Ventures Fund Vii, L.p. owns 36,984,282 shares of American Express Co (AXP) as of August 30, 2018, with a value of $8.5 Billion and a weighting of 99.71%. Vivo Ventures Fund Vii, L.p. owns 5,294,825 shares of Codexis Inc (CDXS) as of September 8, 2016, with a value of $21 Million and a weighting of 0.24%. Vivo Ventures Fund Vii, L.p. also owns 2,858,569 shares of Aclaris Therapeutics Inc (ACRS) as of March 2, 2017, with a value of $4 Million and a weighting of 0.05%.
Latest Holdings of Vivo Ventures Fund Vii, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AXP | American Express Co | 2018-08-30 | 36,984,282 | 230.77 | 8,534,862,757 |
| CDXS | Codexis Inc | 2016-09-08 | 5,294,825 | 3.92 | 20,755,714 |
| ACRS | Aclaris Therapeutics Inc | 2017-03-02 | 2,858,569 | 1.36 | 3,887,654 |
Holding Weightings of Vivo Ventures Fund Vii, L.p.
Vivo Ventures Fund Vii, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivo Ventures Fund Vii, L.p. has made a total of 0 transactions in American Express Co (AXP) over the past 5 years. The most-recent trade in American Express Co is the acquisition of 20,142,123 shares on August 30, 2018, which cost Vivo Ventures Fund Vii, L.p. around $3 Million.
According to the SEC Form 4 filings, Vivo Ventures Fund Vii, L.p. has made a total of 0 transactions in Codexis Inc (CDXS) over the past 5 years. The most-recent trade in Codexis Inc is the sale of 111,600 shares on September 8, 2016, which brought Vivo Ventures Fund Vii, L.p. around $474,300.
According to the SEC Form 4 filings, Vivo Ventures Fund Vii, L.p. has made a total of 0 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years. The most-recent trade in Aclaris Therapeutics Inc is the sale of 425,000 shares on March 2, 2017, which brought Vivo Ventures Fund Vii, L.p. around $13 Million.
Insider Trading History of Vivo Ventures Fund Vii, L.p.
- 1
Vivo Ventures Fund Vii, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Vivo Ventures Fund Vii, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vivo Ventures Fund Vii, L.p. is 5.69%. GuruFocus also compares Vivo Ventures Fund Vii, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Vivo Ventures Fund Vii, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vivo Ventures Fund Vii, L.p.'s insider trading performs compared to the benchmark.
Performance of Vivo Ventures Fund Vii, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.24 | | | | | |
| Relative Return to S&P 500(%) | -0.2 | | | | | |
Vivo Ventures Fund Vii, L.p. Ownership Network
Vivo Ventures Fund Vii, L.p. Owned Company Details
What does Sierra Oncology Inc do?
Who are the key executives at Sierra Oncology Inc?
Vivo Ventures Fund Vii, L.p. is the 10 percent owner of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .
Sierra Oncology Inc (SRRA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sierra Oncology Inc Insider Transactions
Vivo Ventures Fund Vii, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Vivo Ventures Fund Vii, L.p.. You might contact Vivo Ventures Fund Vii, L.p. via mailing address: 505 Hamilton Avenue, Suite 200, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
